Cargando…
One-Year Clinical Outcomes of Ultra Long Apollo Polymer-Based Paclitaxel-Eluting Stents in Patients with Complex, Long Coronary Artery Lesions
BACKGROUND: For all the wealth of research comparing the efficacy of the different types of the drug-eluting stent (DES) such as sirolimus-, paclitaxel-, and zotarolimus-eluting stents, there is still a dearth of data on the different brands of each DES type. We aimed to investigate the one-year cli...
Autores principales: | Salarifar, Mojtaba, Kassaian, Seyed Ebrahim, Alidoosti, Mohammad, Haji-Zeinali, Ali Mohammad, Poorhoseini, Hamid Reza, Nematipour, Ebrahim, Amirzadegan, Alireza, Saroukhani, Sepideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466894/ https://www.ncbi.nlm.nih.gov/pubmed/23074620 |
Ejemplares similares
-
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013) -
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
por: Nozari, Younes, et al.
Publicado: (2015) -
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Poorhosseini, Hamid Reza, et al.
Publicado: (2012) -
Outcomes of Percutaneous Coronary Intervention on Saphenous Vein Graft and Native Coronary Vessels
por: Alidoosti, Mohammad, et al.
Publicado: (2011) -
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
por: Kassaian, Seyed-Ebrahim, et al.
Publicado: (2015)